C3 and preeclampsia: Several recent studies indicating elevated C3a, increased placental MAC deposition and association between CD46 mutations and preeclampsia suggest that in preeclampsia patients complement activation is increased at the feto-maternal interface possibly secondary to defective regulation [15,21,23].